136 related articles for article (PubMed ID: 23072892)
21. Assays for functional binding of plasminogen to viral proteins.
Goto H; Kawaoka Y
Methods; 2000 Jun; 21(2):159-63. PubMed ID: 10816377
[TBL] [Abstract][Full Text] [Related]
22. Endogenous protease-dependent replication of human influenza viruses in two MDCK cell lines.
Noma K; Kiyotani K; Kouchi H; Fujii Y; Egi Y; Tanaka K; Yoshida T
Arch Virol; 1998; 143(10):1893-909. PubMed ID: 9856079
[TBL] [Abstract][Full Text] [Related]
23. Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutinin.
Zmora P; Molau-Blazejewska P; Bertram S; Walendy-Gnirß K; Nehlmeier I; Hartleib A; Moldenhauer AS; Konzok S; Dehmel S; Sewald K; Brinkmann C; Curths C; Knauf S; Gruber J; Mätz-Rensing K; Dahlmann F; Braun A; Pöhlmann S
PLoS One; 2017; 12(5):e0176597. PubMed ID: 28493964
[TBL] [Abstract][Full Text] [Related]
24. [The role of cleavage activation of the hemagglutinin by host and bacterial proteases in the induction of the pathogenesis of influenza viruses].
Tashiro M
Nihon Rinsho; 1997 Oct; 55(10):2633-9. PubMed ID: 9360383
[TBL] [Abstract][Full Text] [Related]
25. Proteolytic activation of the 1918 influenza virus hemagglutinin.
Chaipan C; Kobasa D; Bertram S; Glowacka I; Steffen I; Tsegaye TS; Takeda M; Bugge TH; Kim S; Park Y; Marzi A; Pöhlmann S
J Virol; 2009 Apr; 83(7):3200-11. PubMed ID: 19158246
[TBL] [Abstract][Full Text] [Related]
26. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation.
Galloway SE; Reed ML; Russell CJ; Steinhauer DA
PLoS Pathog; 2013 Feb; 9(2):e1003151. PubMed ID: 23459660
[TBL] [Abstract][Full Text] [Related]
27. Cleavage of influenza a virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases.
Zhirnov OP; Ikizler MR; Wright PF
J Virol; 2002 Sep; 76(17):8682-9. PubMed ID: 12163588
[TBL] [Abstract][Full Text] [Related]
28. Attachment of infectious influenza A viruses of various subtypes to live mammalian and avian cells as measured by flow cytometry.
Rimmelzwaan GF; Nieuwkoop NJ; de Mutsert G; Boon AC; Kuiken T; Fouchier RA; Osterhaus AD
Virus Res; 2007 Nov; 129(2):175-81. PubMed ID: 17714820
[TBL] [Abstract][Full Text] [Related]
29. Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.
Kido H; Okumura Y; Yamada H; Le TQ; Yano M
Curr Pharm Des; 2007; 13(4):405-14. PubMed ID: 17311557
[TBL] [Abstract][Full Text] [Related]
30. [Structure and function of the hemagglutinin of influenza viruses].
Nobusawa E
Nihon Rinsho; 1997 Oct; 55(10):2562-9. PubMed ID: 9360372
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors.
Gubareva LV
Virus Res; 2004 Jul; 103(1-2):199-203. PubMed ID: 15163510
[TBL] [Abstract][Full Text] [Related]
32. Aprotinin and similar protease inhibitors as drugs against influenza.
Zhirnov OP; Klenk HD; Wright PF
Antiviral Res; 2011 Oct; 92(1):27-36. PubMed ID: 21802447
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of influenza virus replication by plant-derived isoquercetin.
Kim Y; Narayanan S; Chang KO
Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
[TBL] [Abstract][Full Text] [Related]
34. Role of hemagglutinin cleavage for the pathogenicity of influenza virus.
Steinhauer DA
Virology; 1999 May; 258(1):1-20. PubMed ID: 10329563
[TBL] [Abstract][Full Text] [Related]
35. Ching-fang-pai-tu-san inhibits the release of influenza virus.
Hsieh CF; Yen HR; Liu CH; Lin S; Horng JT
J Ethnopharmacol; 2012 Dec; 144(3):533-44. PubMed ID: 23041224
[TBL] [Abstract][Full Text] [Related]
36. The Hemagglutinin of Bat-Associated Influenza Viruses Is Activated by TMPRSS2 for pH-Dependent Entry into Bat but Not Human Cells.
Hoffmann M; Krüger N; Zmora P; Wrensch F; Herrler G; Pöhlmann S
PLoS One; 2016; 11(3):e0152134. PubMed ID: 27028521
[TBL] [Abstract][Full Text] [Related]
37. In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives.
Zu M; Yang F; Zhou W; Liu A; Du G; Zheng L
Antiviral Res; 2012 Jun; 94(3):217-24. PubMed ID: 22521753
[TBL] [Abstract][Full Text] [Related]
38. TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells.
Bertram S; Glowacka I; Blazejewska P; Soilleux E; Allen P; Danisch S; Steffen I; Choi SY; Park Y; Schneider H; Schughart K; Pöhlmann S
J Virol; 2010 Oct; 84(19):10016-25. PubMed ID: 20631123
[TBL] [Abstract][Full Text] [Related]
39. A mutant H3N2 influenza virus uses an alternative activation mechanism in TMPRSS2 knockout mice by loss of an oligosaccharide in the hemagglutinin stalk region.
Sakai K; Sekizuka T; Ami Y; Nakajima N; Kitazawa M; Sato Y; Nakajima K; Anraku M; Kubota T; Komase K; Takehara K; Hasegawa H; Odagiri T; Tashiro M; Kuroda M; Takeda M
J Virol; 2015 May; 89(9):5154-8. PubMed ID: 25673722
[TBL] [Abstract][Full Text] [Related]
40. Antiviral effect of strictinin on influenza virus replication.
Saha RK; Takahashi T; Kurebayashi Y; Fukushima K; Minami A; Kinbara N; Ichitani M; Sagesaka YM; Suzuki T
Antiviral Res; 2010 Oct; 88(1):10-8. PubMed ID: 20615432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
